
The St. Jude Fellowship in Pediatric Cancer Predisposition offers training in germline precision medicine to optimize clinical care for children with cancer. Fellows will enhance clinical expertise in diagnosing hereditary cancer predisposition syndromes in infants, children, adolescents, and young adults; develop multidisciplinary management approaches; and apply knowledge from tumor and germline genomic testing to understand cancer risk and treatment impacts. This one-year program provides advanced training in cancer genetics along with research opportunities focused on hereditary cancer predisposition.
Fellows receive professional and research allowances, tuition and dependent care assistance, a personal computer, moving allowance, employer retirement savings contributions, health and fitness facilities, flexible savings accounts, and medical, dental, vision, disability, long term disability, and group life insurance. The program is located in Memphis, Tennessee, offering a relaxed and affordable lifestyle with cultural and recreational amenities.
Eligibility:
Candidates must be American Board of Pediatrics eligible for pediatric hematology-oncology or equivalent training. International applicants must be ECFMG certified and H1B eligible.
Application:
Applications accepted anytime with interviews typically in the fall for a July 1 start.
About St. Jude:
St. Jude Children's Research Hospital in Memphis is a premier research and treatment center for pediatric catastrophic illnesses, including cancer and hematologic conditions. It is a National Cancer Institute-designated Comprehensive Cancer Center dedicated solely to children and is recognized as a top pediatric cancer hospital with a focus on patient-family centered care.